Andres McAllister

Chief Tech/Sci/R&D Officer presso BIOINVENT INTERNATIONAL AB

Patrimonio netto: 4 784 $ in data 31/03/2024

68 anni

36 relazioni

Health Technology

Consumer Services

Miscellaneous

Posizioni attive di Andres McAllister

Società	Posizione	Inizio	Fine
BIOINVENT INTERNATIONAL AB	Chief Tech/Sci/R&D Officer	01/01/2017	-

Storia della carriera di Andres McAllister

Precedenti posizioni note di Andres McAllister

Società	Posizione	Inizio	Fine
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Chief Tech/Sci/R&D Officer	01/09/2004	01/09/2015
Immunexpress Pty Ltd. Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia.	Director/Board Member	-	-
Centre d'Immunologie Pierre Fabre	Corporate Officer/Principal	-	-
Institut Pasteur Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.	Corporate Officer/Principal	-	-
The University of California, San Francisco	Corporate Officer/Principal	-	-
IMMUNE DESIGN CORP	Chief Tech/Sci/R&D Officer	-	-

Formazione di Andres McAllister

Université Paris 1 Panthéon-Sorbonne	Doctorate Degree
Universidad del Rosario	Doctorate Degree

Statistiche

Distribuzione geografica

Francia	4
Stati Uniti	3
Svezia	2

Posizioni

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	3
Doctorate Degree	2

Settori

Health Technology	5
Consumer Services	4
Miscellaneous	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	1
BIOINVENT INTERNATIONAL AB	Health Technology

Aziende private	5
Institut Pasteur Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.	Miscellaneous
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Health Technology
Immune Design Corp. Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ.	Health Technology
Immunexpress Pty Ltd. Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia.	Health Technology
Centre d'Immunologie Pierre Fabre

Vedi le connessioni aziendali